您的位置: 首页 > 农业专利 > 详情页

SOLUBLE PROTEIN CD5 OR CD6 FOR THE TREATMENT OF CANCER OR TUMOR OR FOR USE AS AN ADJUVANT
专利权人:
发明人:
申请号:
EP12726052.9
公开号:
EP2714066A1
申请日:
2012.05.29
申请国别(地区):
EP
年份:
2014
代理人:
摘要:
The present invention discloses soluble isoforms of CD5 and CD6, which are scavenger-like lymphocyte receptors, for use in the prophylaxis or therapy of disorders or in therapeutic interventions, which would benefit from an exacerbated immune response to either endogenous or exogenous antigens, resulting from a decrease in lymphocyte subpopulations with regulatory functions and/or increase in lymphocyte subpopulations with effector functions. Special disorders are cell growth disorders, and chronic infections of bacterial, viral, fungal or parasitic origin. The invention also provides animal models for the study and the prophylaxis/treatment of autoimmune diseases, cancer, and chronic infections.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充